Dynamics of Bagaza, West Nile, and Usutu viruses in Portugal revealed by long-term serological surveillance in red-legged partridges, 2018-2022

Fontoura-Goncalves, C.; Llorente, F.; Perez-Ramirez, E.; Jimenez-Clavero, M. A.; Costa, J. B.; de Mello, G.; Goncalves, D.; Alves, P. C.; Hofle, U.; Queiros, J.

doi:10.1101/2024.08.02.606292

bioRxiv · 10.1101/2024.08.02.606292

Dynamics of Bagaza, West Nile, and Usutu viruses in Portugal revealed by long-term serological surveillance in red-legged partridges, 2018-2022

Fontoura-Goncalves, C.·Llorente, F.·Perez-Ramirez, E.·Jimenez-Clavero, M. A.·Costa, J. B.·de Mello, G.·Goncalves, D.·Alves, P. C.·Hofle, U.·Queiros, J.

View original source ↗Export metadata ↓

Abstract

BackgroundBagaza virus (BAGV) emerged in Portugal in 2021. BAGV and other flaviviruses such as West Nile virus (WNV) and Usutu virus (USUV) represent emerging threats in Europe, yet uncertainties persist regarding their epidemiological status in Portugal. AimThis study aimed to elucidate the epidemiological dynamics of BAGV, WNV, and USUV in Portugal using the red-legged partridge (Alectoris rufa) as a susceptible bird model species. MethodsSerum samples collected from a partridge population in Southern Portugal, between 2018 and 2022, were analysed to characterize exposure to flaviviruses through enzyme-linked immunosorbent assay (ELISA; n=468) and virus neutralization test (VNT; n=433). ResultsELISA test revealed an average seroprevalence of 58.1% for WNV and WNV-cross-reacting antibodies between 2018 and 2022, while 66.3% of individuals tested positive using VNT: 28.8% specific for WNV, 8.1% for BAGV, 2.1% for USUV and 27.2% for "undetermined flaviviruses". BAGV seroprevalence was first detected in October 2021 (8.7%), alongside an outbreak detection, peaking in November 2021 (26.3%) and persisting until October 2022 (2.3%). WNV antibodies were detected throughout all sampling periods, with the highest seroprevalence in October 2020 (44.8%). USUV seroprevalence was detected until the BAGV outbreak in 2021, peaking in October 2020 (6.9%). ConclusionLong-term serological surveillance of partridges revealed endemic circulation of WNV and sporadic circulation of BAGV and USUV in Portugal. Notably, the highest WNV seroprevalence coincided with the human WNV outbreak in southern Spain in the summer of 2020, highlighting the role of red-legged partridges in the transmission/maintenance cycle and as sentinels of flaviviruses circulation.

Explore related subjects

immunology Preprint

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

Fontoura-Goncalves, C., Llorente, F., Perez-Ramirez, E., Jimenez-Clavero, M. A., Costa, J. B., de Mello, G., Goncalves, D., Alves, P. C., Hofle, U., Queiros, J.. 2024-08-06. Dynamics of Bagaza, West Nile, and Usutu viruses in Portugal revealed by long-term serological surveillance in red-legged partridges, 2018-2022. https://doi.org/10.1101/2024.08.02.606292

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

Ksp37 is a rapidly mobilized NK cell secretory protein that engages FGF2

A key feature of natural killer (NK) cells is their preloaded arsenal of effector molecules, allowing them to rapidly respond upon activation. In this study, we characterized a previously unexplored secretory protein, termed killer-specific secretory protein of 37 kDa (Ksp37), which is highly abundant in differentiated CD56dim NK cells. Ksp37 is rapidly secreted in a dose-dependent and JAK-1 dependent manner upon low levels of cytokine stimulation, making it a sensitive readout for NK cell activation. Following secretion, intracellular levels were rapidly replenished, preserving responsiveness to subsequent cytokine stimulation. We found that Ksp37 is stored in polarized intracellular compartments distinct from those containing canonical cytotoxic effector molecules, including granzyme B and perforin, which require stronger stimulation for release. Lastly, we identified Ksp37 as a novel binding partner of fibroblast growth factor 2 (FGF2). This opens new avenues of exploration for the role of NK cells in remodeling their extracellular environment by modulating the FGF2-FGFR1 axis, which plays a key role in tumor growth, angiogenesis and tissue repair.

immunology↗

bioRxiv2026

ACE-engineered human iPSC-derived neutrophils enhance host defense against multidrug-resistant bacterial infections

Severe neutropenia predisposes patients to life-threatening infections, while donor-dependent granulocyte transfusions are limited by availability and variable cell quality. Here, we engineered human induced pluripotent stem cells (iPSCs) to constitutively or inducibly express angiotensin-converting enzyme (ACE) and differentiated them into functional ACE-engineered neutrophils (ACE-iNeu). ACE expression enhanced granulocytic maturation, reactive oxygen species generation, inflammatory cytokine production, and antimicrobial signaling. ACE-iNeu exhibited enhanced bactericidal activity against methicillin-resistant Staphylococcus aureus and multidrug-resistant Pseudomonas aeruginosa. Following adoptive transfer into neutropenic mice, ACE-iNeu significantly reduced circulating and tissue bacterial burdens. Integrated metabolomic and transcriptomic analyses revealed ACE-associated alterations in adenine nucleotide abundance and developmental and inflammatory pathways. Together, these findings establish ACE engineering as a strategy to enhance the production and antimicrobial function of human iPSC-derived neutrophils and support further preclinical development of engineered granulocyte therapies for severe drug-resistant infections.

immunology↗

bioRxiv2026

Tetravalent dengue mRNA vaccination orchestrates balanced four-serotype immunity with durable memory and protection in mice.

An effective dengue vaccine must establish durable immunity across four dengue virus (DENV) serotypes, evade antibody-dependent enhancement (ADE), and overcome immune imprinting from prior exposure. Here, we developed TetprM-E mRNA-LNP, a tetravalent vaccine comprising LNP-formulated nucleoside-modified mRNAs encoding DENV1-4 precursor membrane-envelope (prM-E) antigens, and evaluated its immunogenicity, durability, protection and breath across serotype-specific immune backgrounds. Three immunization strategies elicited neutralizing titers greater than 1:1500 against each serotype. Passive transfer of immune sera conferred 100% survival and reduced viremia after lethal DENV2 challenge in immunocompromised mice. Vaccination induced DENV envelope (env)-specific CD8+T cells and CD4-dependent germinal-center responses. DENV env-binding antibodies persisted for 34 weeks alongside DENV env-specific memory B cells. Vaccine-elicited sera showed no measurable in vitro ADE. Although monovalent priming initially biased antibody responses, TetprM-E mRNA-LNP vaccination broadened neutralization across DENV1-4 regardless of priming serotype. Together, TetprM-E mRNA-LNP elicits broad, durable, and protective immunity despite serologic constraints from pre-existing immunity.

immunology↗